< Back to previous page
Patent
PHOSPHOLIPID PROFILING OF CANCER
In general, the present invention provides prognostic and predictive methods and kits for determining the lipogenicity of a tumor in a subject, by making use of phospholipid profiling, whereby a relative increase in mono-unsaturated phospholipid species in combination with a relative decrease in poly-unsaturated phospholipid species is indicative for a more resistant and aggressive lipogenic cancer phenotype.
Patent Publication Number: EP2534488
Year filing: 2011
Year approval: 2014
Year publication: 2014
Status: Assigned
URI: link to Espacenet
Technology domains: Analysis of biological materials
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven